Abstract
More than 250 million people worldwide are chronically infected with the hepatitis B virus (HBV). In this Comment, members of the International Coalition to Eliminate HBV appraise the current policy environment and the need for appropriate cure research and preparedness to complement the WHO global elimination strategy, the HBV vaccine and the well-tolerated but poorly accessed therapy.
Original language | English |
---|---|
Pages (from-to) | 517-518 |
Number of pages | 2 |
Journal | Nature Reviews Gastroenterology and Hepatology |
Volume | 15 |
Issue number | 9 |
DOIs |
|
State | Published - 1 Sep 2018 |
Externally published | Yes |